Pictet Asset Management Holding Sa Vaxcyte, Inc. Transaction History
Pictet Asset Management Holding Sa
- $85.6 Billion
- Q2 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 532,904 shares of PCVX stock, worth $60.3 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
532,904
Previous 861,569
38.15%
Holding current value
$60.3 Million
Previous $58.9 Million
31.63%
% of portfolio
0.05%
Previous 0.07%
Shares
4 transactions
Others Institutions Holding PCVX
# of Institutions
286Shares Held
110MCall Options Held
248KPut Options Held
109K-
Black Rock Inc. New York, NY9.94MShares$1.12 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.8MShares$1.11 Billion0.01% of portfolio
-
Janus Henderson Group PLC London, X08.87MShares$1 Billion0.37% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.2MShares$928 Million9.34% of portfolio
-
Wellington Management Group LLP Boston, MA4.59MShares$519 Million0.06% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $6.71B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...